DD148776A5 - Verfahren zur herstellung neuer phenanthrolinderivate - Google Patents
Verfahren zur herstellung neuer phenanthrolinderivate Download PDFInfo
- Publication number
- DD148776A5 DD148776A5 DD80218467A DD21846780A DD148776A5 DD 148776 A5 DD148776 A5 DD 148776A5 DD 80218467 A DD80218467 A DD 80218467A DD 21846780 A DD21846780 A DD 21846780A DD 148776 A5 DD148776 A5 DD 148776A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- formula
- carbon atoms
- salt
- compound
- oxo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pulmonology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH40279 | 1979-01-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
DD148776A5 true DD148776A5 (de) | 1981-06-10 |
Family
ID=4186203
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DD80218467A DD148776A5 (de) | 1979-01-16 | 1980-01-15 | Verfahren zur herstellung neuer phenanthrolinderivate |
Country Status (15)
Country | Link |
---|---|
US (1) | US4297358A (xx) |
EP (1) | EP0013666A1 (xx) |
JP (1) | JPS5598182A (xx) |
AU (1) | AU5460980A (xx) |
DD (1) | DD148776A5 (xx) |
DK (1) | DK16480A (xx) |
ES (5) | ES487661A0 (xx) |
FI (1) | FI800100A (xx) |
GR (1) | GR70371B (xx) |
IL (1) | IL59130A0 (xx) |
NO (1) | NO800085L (xx) |
NZ (1) | NZ192622A (xx) |
PL (1) | PL221367A1 (xx) |
PT (1) | PT70695A (xx) |
ZA (1) | ZA80254B (xx) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4652567A (en) * | 1985-03-13 | 1987-03-24 | Hoechst-Roussel Pharmaceuticals Inc. | Benzo(c)-1,5-naphthyridines useful for treating a patient having drug induced memory impairment in need of memory enhancement |
WO2006014605A2 (en) * | 2004-07-23 | 2006-02-09 | Polnox Corporation | Anti-oxidant macromonomers and polymers and methods of making and using the same |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3313817A (en) * | 1964-01-27 | 1967-04-11 | Sterling Drug Inc | 4-alkyl (and alkenyl)-1-oxo-1, 4-dihydro-4, 7-phenanthroline-2-carboxylic acid derivatives |
US3790577A (en) * | 1970-10-05 | 1974-02-05 | Ici Ltd | Pyridoquinoline dicarboxylic acid derivatives |
US4156726A (en) * | 1974-12-07 | 1979-05-29 | Fisons Limited | 4-Oxo-2-carboxyl quinoline derivatives used as antiallergic compounds |
-
1980
- 1980-01-04 US US06/109,715 patent/US4297358A/en not_active Expired - Lifetime
- 1980-01-10 EP EP80810010A patent/EP0013666A1/de not_active Withdrawn
- 1980-01-14 FI FI800100A patent/FI800100A/fi not_active Application Discontinuation
- 1980-01-14 ES ES487661A patent/ES487661A0/es active Granted
- 1980-01-14 GR GR60956A patent/GR70371B/el unknown
- 1980-01-15 AU AU54609/80A patent/AU5460980A/en not_active Abandoned
- 1980-01-15 IL IL59130A patent/IL59130A0/xx unknown
- 1980-01-15 DK DK16480A patent/DK16480A/da not_active Application Discontinuation
- 1980-01-15 PT PT70695A patent/PT70695A/pt unknown
- 1980-01-15 NO NO800085A patent/NO800085L/no unknown
- 1980-01-15 ZA ZA00800254A patent/ZA80254B/xx unknown
- 1980-01-15 DD DD80218467A patent/DD148776A5/de unknown
- 1980-01-15 NZ NZ192622A patent/NZ192622A/xx unknown
- 1980-01-15 PL PL22136780A patent/PL221367A1/xx unknown
- 1980-01-16 JP JP269180A patent/JPS5598182A/ja active Pending
- 1980-08-29 ES ES494606A patent/ES494606A0/es active Granted
- 1980-08-29 ES ES494604A patent/ES494604A0/es active Granted
- 1980-08-29 ES ES494605A patent/ES8106520A1/es not_active Expired
- 1980-08-29 ES ES494603A patent/ES8106519A1/es not_active Expired
Also Published As
Publication number | Publication date |
---|---|
GR70371B (xx) | 1982-09-30 |
IL59130A0 (en) | 1980-05-30 |
ES8106521A1 (es) | 1981-08-16 |
ES8106522A1 (es) | 1981-08-16 |
ES494604A0 (es) | 1981-08-16 |
ES494603A0 (es) | 1981-08-16 |
ZA80254B (en) | 1980-12-31 |
PL221367A1 (xx) | 1980-12-01 |
ES8106519A1 (es) | 1981-08-16 |
JPS5598182A (en) | 1980-07-25 |
NZ192622A (en) | 1982-03-16 |
ES494605A0 (es) | 1981-08-16 |
EP0013666A1 (de) | 1980-07-23 |
FI800100A (fi) | 1980-07-17 |
ES8102127A1 (es) | 1980-12-16 |
ES487661A0 (es) | 1980-12-16 |
DK16480A (da) | 1980-07-17 |
AU5460980A (en) | 1980-07-24 |
NO800085L (no) | 1980-07-17 |
ES8106520A1 (es) | 1981-08-16 |
PT70695A (en) | 1980-02-01 |
US4297358A (en) | 1981-10-27 |
ES494606A0 (es) | 1981-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2614406C2 (xx) | ||
DE1695556C3 (de) | 3-Alkyl-1,2,3,4,4a,9-hexahydropyrazino[1,2-f]morphanthridinderivate | |
DE3033157A1 (de) | 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel | |
CH650782A5 (de) | Carbostyrilverbindungen, verfahren zu deren herstellung und arzneimittel, welche diese enthalten. | |
EP0080602A1 (de) | Substituierte Benzimidazole, Verfahren zu ihrer Herstellung, ihre Anwendung und sie enthaltende Arzneimittel | |
EP0658559A1 (de) | Thienothiazinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als 5-dipoxygenase und Cyclooxygenaseinhibitoren | |
DE1958918A1 (de) | Chemische Verfahren und Produkte | |
EP0022078B1 (de) | Pyrazolochinoline, Verfahren zu ihrer Herstellung, und pharmazeutische Präparate enthaltend diese Verbindungen | |
EP0062001B1 (de) | Acyl-chinolinonderivate, Verfahren zu ihrer Herstellung, diese enthaltende pharmazeutische Präparate und ihre Verwendung | |
EP0071935B1 (de) | 1-Phenyl-2-aminocarbonylindol-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
DE69008542T2 (de) | Chinolinderivate, ihre herstellung und verwendung. | |
EP0185909B1 (de) | 5-Alkyl-1-phenyl-2-piperazinoalkylpyrazolin-3-on-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
EP0116360B1 (de) | 1-Phenyl-2-aminocarbonylindol-Verbindungen sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
EP0039519B1 (de) | Substituierte Thienotricyclen, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel | |
DE2737407A1 (de) | Verfahren zur herstellung neuer benzopyranderivate | |
EP0072960B1 (de) | 1,5-Diphenylpyrazolin-3-on-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
EP0012925B1 (de) | Neue Chinoloncarbonsäure-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate | |
EP0576906A1 (de) | Neue Thienothiazinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Antiinflammatorium und Analgeticum | |
EP0000488A1 (de) | 3-Oxaloamino-4-oxo-4H-1-benzopyranderivaten, Verfahren zu deren Herstellung und deren pharmazeutischen Verwendung | |
DD148776A5 (de) | Verfahren zur herstellung neuer phenanthrolinderivate | |
EP0064255A1 (de) | Benzopyranylether, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel und Zwischenprodukte | |
AT391316B (de) | Neue thienyloxy-alkylamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
EP0717044A1 (de) | Thienopyridonderivate, deren Herstellung und deren Verwendung als NMDA-Rezeptor Antagonisten | |
DE2832358C2 (xx) | ||
EP0072961A1 (de) | 1-Phenylindazol-3-on-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |